Clinical Trials Browser

Withdrawn × Esophageal Neoplasms × nimotuzumab × Clear all

NCT02034968 2015-03-05

Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma

Phase 2 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02041819 2015-03-05

Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus

Phase 2 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms